• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向胃癌调节性 T 细胞:发病机制、免疫治疗和预后。

Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis.

机构信息

The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050011 Shijiazhuang, China.

The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050011 Shijiazhuang, China.

出版信息

Biomed Pharmacother. 2023 Feb;158:114180. doi: 10.1016/j.biopha.2022.114180. Epub 2022 Dec 30.

DOI:10.1016/j.biopha.2022.114180
PMID:36586241
Abstract

Gastric cancer (GC) remains one of the most common malignancies worldwide. Despite immune-checkpoint inhibitors (ICIs) has revolutionized cancer treatment and obtained durable clinical responses, only a fraction of GC patients benefit from it. As an important component of T cells, regulatory T cells (Tregs) play a vital role in the pathogenesis of GC, keep a core balance between immune suppression and autoimmunity, and function as predictive biomarkers for prognosis of GC patients. In this review, we discuss the role of Tregs in the pathogenesis of GC, and targeting Tregs via influencing their transcription factor, migration, co-stimulatory receptors, immune checkpoints, and cytokines. We also focus on the currently important findings of Tregs metabolism including amino acid, fatty acid, and lactic acid metabolism of GC. The emerging role of microbiome and clinical combined therapy in modulating Tregs in GC treatment is also summarized. Meanwhile, this review recapitulates a novel regulator, magnesium, is involved in mediating Tregs in GC. These research advances on Treg-related strategies provide new insights and challenges for GC progression, treatment, and prognosis. And we hope our review can stimulate further discovery and implication of mediators and pathways targeting Tregs.

摘要

胃癌(GC)仍然是全球最常见的恶性肿瘤之一。尽管免疫检查点抑制剂(ICIs)彻底改变了癌症治疗,并获得了持久的临床反应,但只有少数 GC 患者从中受益。调节性 T 细胞(Tregs)作为 T 细胞的重要组成部分,在 GC 的发病机制中发挥着重要作用,在免疫抑制和自身免疫之间保持着核心平衡,并作为 GC 患者预后的预测生物标志物。在这篇综述中,我们讨论了 Tregs 在 GC 发病机制中的作用,并通过影响其转录因子、迁移、共刺激受体、免疫检查点和细胞因子来靶向 Tregs。我们还重点介绍了 Tregs 代谢的当前重要发现,包括 GC 中氨基酸、脂肪酸和乳酸代谢。微生物组和临床联合治疗在调节 GC 中 Tregs 方面的新兴作用也得到了总结。同时,本综述回顾了一种新型调节剂镁,它参与了 GC 中 Tregs 的调节。这些关于 Treg 相关策略的研究进展为 GC 的进展、治疗和预后提供了新的见解和挑战。我们希望我们的综述能够激发对 Tregs 靶向调节剂和途径的进一步发现和应用。

相似文献

1
Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis.靶向胃癌调节性 T 细胞:发病机制、免疫治疗和预后。
Biomed Pharmacother. 2023 Feb;158:114180. doi: 10.1016/j.biopha.2022.114180. Epub 2022 Dec 30.
2
Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy.胃癌中的调节性 T 细胞:从发病机制到治疗的关键控制器。
Cancer Treat Rev. 2023 Nov;120:102629. doi: 10.1016/j.ctrv.2023.102629. Epub 2023 Sep 23.
3
Recent advances in the study of regulatory T cells in gastric cancer.胃癌调节性 T 细胞研究的新进展。
Int Immunopharmacol. 2019 Aug;73:560-567. doi: 10.1016/j.intimp.2019.05.009. Epub 2019 Jun 7.
4
Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.理解和靶向人类癌症调节性 T 细胞以改善治疗。
Adv Exp Med Biol. 2021;1278:229-256. doi: 10.1007/978-981-15-6407-9_12.
5
<Editors' Choice> Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.《编辑推荐》:干预调节者:抑制调节性T细胞并增强抗肿瘤免疫力。
Nagoya J Med Sci. 2019 Feb;81(1):1-18. doi: 10.18999/nagjms.81.1.1.
6
Selective targeting or reprogramming of intra-tumoral Tregs.肿瘤内调节性T细胞的选择性靶向或重编程。
Med Oncol. 2024 Feb 11;41(3):71. doi: 10.1007/s12032-024-02300-0.
7
Targeting regulatory T cell metabolism in disease: Novel therapeutic opportunities.靶向调节性 T 细胞代谢治疗疾病:新的治疗机会。
Eur J Immunol. 2023 Sep;53(9):e2250002. doi: 10.1002/eji.202250002. Epub 2023 Apr 4.
8
Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.平衡癌症免疫疗法和免疫相关不良事件:调节性 T 细胞的新作用。
J Autoimmun. 2019 Nov;104:102310. doi: 10.1016/j.jaut.2019.102310. Epub 2019 Aug 15.
9
Notch signaling pathway regulates CD4CD25CD127 regulatory T cells and T helper 17 cells function in gastric cancer patients.Notch 信号通路调节 CD4CD25CD127 调节性 T 细胞和辅助性 T 细胞 17 细胞在胃癌患者中的功能。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20182044. Print 2019 May 31.
10
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity.调节性 T 细胞的代谢特征及其对肿瘤微环境的适应:对抗肿瘤免疫的影响。
J Hematol Oncol. 2022 Aug 10;15(1):104. doi: 10.1186/s13045-022-01322-3.

引用本文的文献

1
Effects of polyunsaturated fatty acids on gastric cancer immunity and immunotherapy.多不饱和脂肪酸对胃癌免疫及免疫治疗的影响。
Sci Rep. 2025 Jun 6;15(1):19891. doi: 10.1038/s41598-025-97644-6.
2
Immunopharmacology of gastric cancer-deciphering immune cell subset responses and nanoparticle-mediated targeting.胃癌的免疫药理学——解析免疫细胞亚群反应与纳米颗粒介导的靶向作用
Front Pharmacol. 2025 May 19;16:1611234. doi: 10.3389/fphar.2025.1611234. eCollection 2025.
3
Integrating Mendelian randomization and multi-transcriptomic analyses to unveil the genetic association risk of regulatory T cell-mediated free cholesterol and gastric cancer.
整合孟德尔随机化和多转录组分析以揭示调节性T细胞介导的游离胆固醇与胃癌的遗传关联风险
Discov Oncol. 2025 May 22;16(1):864. doi: 10.1007/s12672-025-02739-1.
4
Gastrointestinal tumor personalized immunotherapy: an integrated analysis from molecular genetics to imaging biomarkers.胃肠道肿瘤个性化免疫治疗:从分子遗传学到影像生物标志物的综合分析
Therap Adv Gastroenterol. 2025 Apr 23;18:17562848251333527. doi: 10.1177/17562848251333527. eCollection 2025.
5
The Mechanism of Sijunzi Decoction Suppresses Gastric Cancer Metastasis via the m6A Methyltransferase METTL14 Based on Untargeted Metabolomics Studies and Network Pharmacology Analysis.基于非靶向代谢组学研究和网络药理学分析探讨四君子汤通过m6A甲基转移酶METTL14抑制胃癌转移的机制
Drug Des Devel Ther. 2025 Mar 31;19:2369-2392. doi: 10.2147/DDDT.S506702. eCollection 2025.
6
Role of Soluble Cytokine Receptors in Gastric Cancer Development and Chemoresistance.可溶性细胞因子受体在胃癌发生发展及化疗耐药中的作用
Int J Mol Sci. 2025 Mar 12;26(6):2534. doi: 10.3390/ijms26062534.
7
Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer.多种程序性细胞死亡模式可预测胃癌的预后和药物敏感性。
Front Immunol. 2025 Feb 4;16:1511453. doi: 10.3389/fimmu.2025.1511453. eCollection 2025.
8
Analysis of immune status and prognostic model incorporating lactic acid metabolism-associated genes.结合乳酸代谢相关基因的免疫状态分析及预后模型
Cancer Cell Int. 2024 Nov 14;24(1):378. doi: 10.1186/s12935-024-03555-3.
9
Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment.肿瘤微环境中胃癌恶性进展的分子机制。
Int J Mol Sci. 2024 Oct 31;25(21):11735. doi: 10.3390/ijms252111735.
10
T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review).胃癌中T淋巴细胞相关免疫反应及免疫治疗(综述)
Oncol Lett. 2024 Sep 6;28(5):537. doi: 10.3892/ol.2024.14670. eCollection 2024 Nov.